Chen, M.H., Chang, P.M., Chen, P.M., Tzeng, C.H., Chu, P.Y., Chang, S.Y., et al. (2009) Prognostic Significance of a Pretreatment Hematologic Profile in Patients with Head and Neck Cancer. Journal of Cancer Research and Clinical Oncology, 135, 1783-1790.
https://doi.org/10.1007/s00432-009-0625-1

has been cited by the following article:

• TITLE: Prognostic Significance of Hematologic Markers in Patients with Head and Neck Squamous Cell Carcinomas

  AUTHORS: Ryohei Oya, Yukinori Takenaka, Kengo Aoki, Hiroko Hamaguchi, Kazuya Takemura, Masayuki Nozawa, Takahiro Kitamura, Yoshifumi Yamamoto, Atsuhiko Uno

  KEYWORDS: Biomarkers, Head and Neck Cancer, Hematologic Marker

  JOURNAL NAME: International Journal of Otolaryngology and Head & Neck Surgery, Vol.7 No.2, March 22, 2018

  ABSTRACT: Aim: To assess the prognostic value of hematologic markers for cancers of the head and neck region, according to tumor site. Methods: We reviewed the data of 441 patients diagnosed with head and neck squamous cell carcinomas (HNSCC) between 2006 and 2014. Overall survival rates were estimated using the Kaplan-Meier method and Cox proportional hazards models were used to assess the hazard ratio (HR) for death, according to hematologic markers. Results: In the univariate analyses, hemoglobin concentration; leukocyte, neutrophil, monocyte, and platelet counts; and the platelet-lymphocyte ratio were associated with overall survival. In the multivariate analyses, hemoglobin concentration (HR 0.55, 95% confidence interval [CI] 0.38 - 0.78, p Conclusions: Several hematologic markers have prognostic significance for patients with HNSCC, however, the magnitude of the effect depends on the tumor site.